The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.
about
Novel mechanism for mesenchymal stem cells in attenuating peritoneal adhesion: accumulating in the lung and secreting tumor necrosis factor α-stimulating gene-6Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effectInfluence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies?Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-AnalysisHoming and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface DiseasesIncreased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell ImagingMultipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver diseaseAdult Mesenchymal Stem Cells: When, Where, and HowThe Dark Side of the Force - Constraints and Complications of Cell Therapies for StrokePatient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technologyRole of mesenchymal stem cells in bone regeneration and fracture repair: a reviewMesenchymal stem cells as a vector for the inflammatory prostate microenvironmentImmunotherapeutic organoids: a new approach to cancer treatmentStem cell therapy in bladder dysfunction: where are we? And where do we have to go?Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applicationsMesenchymal stem cell transplantation in multiple sclerosisMesenchymal stem cells migration homing and trackingCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsIntraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitisIntraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs.Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantationBiodistribution, migration and homing of systemically applied mesenchymal stem/stromal cellsMesenchymal stem cells in the treatment of chronic lung diseasePharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cellsIntravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6Clinical applications of mesenchymal stem cells in chronic diseases.Cell-based therapies for regenerating bone.Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarctionTargeting mesenchymal stem cells to activated endothelial cells.Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing.Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kineticsAdipose-Derived Mesenchymal Stem Cells (ADSCs) With the Potential to Ameliorate Platelet Recovery, Enhance Megakaryopoiesis, and Inhibit Apoptosis of Bone Marrow Cells in a Mouse Model of Radiation-Induced Thrombocytopenia.Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells.Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.Migration of human umbilical cord blood cells into rat liver.The Characteristics Of Human Bone-Derived Cells (HBDCS) during osteogenesis in vitro.Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantation.Preclinical safety & toxicity evaluation of pooled, allogeneic human bone marrow-derived mesenchymal stromal cells.
P2860
Q21999280-B6D23971-AC80-49B9-A380-364E2AD99DFBQ24635138-2720927B-108C-4366-BF45-372AD007FDB8Q24812198-BE9B1633-B50E-4250-AD35-0AD9BC55AC8AQ26748676-6A231AC7-05C9-46C5-B1E1-B3EAD7FB77B0Q26750318-A916C08D-356C-45A7-8D06-B9019D165BD7Q26750660-FB424DBE-EC45-4BAA-B6CB-424D873F5268Q26753150-2E56BA0B-27EA-4831-9C20-842148174483Q26769618-0615ED98-7409-4B33-BCF9-737592FE9E3BQ26798283-EB09EBB6-9289-4E9C-930D-CFD10B2305C3Q26800181-045AF947-D342-40A9-B350-6A56069262B6Q26821929-4EED5F97-AB68-49F7-9B76-EC5A21B93ADEQ26825380-476515F9-AB33-40FE-A8AE-4E69BC84EC96Q26853374-5AB5ACEB-D041-4E65-9DBA-755CC52A9E20Q26853431-65524872-82C0-4B43-8B87-C30A2BD59967Q26862700-6916FE3E-1593-4705-9F9E-78A195E2504DQ26998695-7FD834C5-9258-4BBF-A03F-70355A4FE7DDQ26999783-33D33363-150D-4E30-A13C-428A407B8931Q27003059-454527D8-7485-4176-87C8-5ED70FA013FAQ27026350-90CA9589-C45B-442D-AE9A-8FB1FE4ACFBCQ27321287-CB546305-EE86-4F0F-8203-D752DDF22057Q27322349-93D939A9-6F1C-44FC-BF35-05090140E506Q27324639-2268230A-F3D1-439A-815B-93C7604C734AQ28069791-5059A8AD-5CD7-43B1-9D33-1700D7BC34F0Q28079373-F17C58EA-E716-4DBD-95CE-387FCFF89E8EQ28540077-44DFFF16-60D8-43F4-BC06-7DEBDFE333E6Q29620590-F9A3A562-9F66-4D76-A45B-3EAEBB0D10DAQ30437823-F10A8B3F-4794-4ABE-87EE-C01E09A59E47Q30444462-6A6B044C-0D61-42D5-BA3A-7881F27C5814Q30477220-9BFC00FE-8A51-41C7-8009-DA0CD678F073Q30488087-9A448C8C-A46E-41BA-B271-78A6276C3938Q30530998-EF5F1EAD-E148-47E2-836D-2230AE70B172Q30541132-B8990619-04FC-4217-B407-1770BF2F899CQ33422819-800D7E1F-98FD-4A94-91D5-F2122229E6F2Q33550608-D1CBCBF9-9A7D-4C17-AA19-6915B3B797BCQ33560685-0128B0F8-403F-4142-9AAB-B6DD5B475E6DQ33570359-70EF6355-BD31-4E35-BFE1-B10EE074AC2AQ33614905-50E681E2-0721-4833-8E12-5AE2C48F450DQ33634970-12E26E16-2D61-4DF4-AB04-49EB86F68130Q33648765-08161970-FABC-4A6D-9B9C-5D570C4F6FE2Q33692346-2EC7231B-25FB-440F-832A-9438C8C3AEF7
P2860
The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
The dynamic in vivo distributi ...... mal stem cells after infusion.
@en
The dynamic in vivo distributi ...... mal stem cells after infusion.
@nl
type
label
The dynamic in vivo distributi ...... mal stem cells after infusion.
@en
The dynamic in vivo distributi ...... mal stem cells after infusion.
@nl
prefLabel
The dynamic in vivo distributi ...... mal stem cells after infusion.
@en
The dynamic in vivo distributi ...... mal stem cells after infusion.
@nl
P2093
P356
P1433
P1476
The dynamic in vivo distributi ...... ymal stem cells after infusion
@en
P2093
P356
10.1159/000047856
P577
2001-01-01T00:00:00Z